1
|
Nitrogen-Containing Bisphosphonates Downregulate Cathepsin K and Upregulate Annexin V in Osteoclasts Cultured In Vitro. Int J Dent 2023; 2023:2960941. [PMID: 36866025 PMCID: PMC9974278 DOI: 10.1155/2023/2960941] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2022] [Revised: 01/12/2023] [Accepted: 01/19/2023] [Indexed: 02/23/2023] Open
Abstract
Introduction Bisphosphonates are widely used in the treatment of osteoporosis; however, they are associated with the serious adverse event of bisphosphonate-related osteonecrosis of the jaw (BRONJ). Aim The aim of this study is to assess the effects of nitrogen-containing bisphosphonates (N-PHs) on the synthesis of IL-1β, TNF-α, sRANKL, cathepsin K, and annexin V in bone cells cultured in vitro. Materials and Methods Osteoblasts and bone marrow-derived osteoclasts were cultured in vitro, subjected to treatment with alendronate, risedronate, or ibandronate at a concentration of 10-5 M for 0 to 96 h and then assayed for IL-1β, sRANKL, and TNF-α production by ELISA. Cathepsin K and Annexin V-FITC staining in osteoclasts were assessed by flow cytometry. Results There was significant downregulation of IL-1β, sRANKL, and TNF-α in experimental osteoblasts compared to control cells, and there was upregulation of IL-1β and downregulation of RANKL and TNF-α in experimental osteoclasts. Furthermore, in osteoclasts, cathepsin K expression was downregulated at 48-72 h with alendronate treatment, while risedronate treatment resulted in upregulated annexin V expression at 48 h compared to the control treatment. Conclusion Bisphosphonates added to bone cells inhibited osteoclastogenesis, which led to the downregulation of cathepsin K and induction of apoptosis in osteoclasts; these changes limited the capacity of bone remodelling and healing that may contribute to BRONJ induced by surgical dental procedures.
Collapse
|
2
|
Fang K, Murakami Y, Kanda S, Shimono T, Dang AT, Ono M, Nishiyama T. Unkeito Suppresses RANKL-Mediated Osteoclastogenesis via the Blimp1-Bcl6 and NF-κB Signaling Pathways and Enhancing Osteoclast Apoptosis. Int J Mol Sci 2022; 23:ijms23147814. [PMID: 35887169 PMCID: PMC9323376 DOI: 10.3390/ijms23147814] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2022] [Revised: 07/12/2022] [Accepted: 07/13/2022] [Indexed: 11/16/2022] Open
Abstract
Osteoporosis is a common bone disease, particularly in menopausal women. Herein, we screened four Kampo medicines (Unkeito (UKT), Kamishoyosan (KSS), Kamikihito (KKT), and Ninjinyoeito (NYT)), frequently used to treat menopausal syndromes, for their effects on receptor activator of nuclear factor-kappaB ligand (RANKL)-induced osteoclast differentiation in RAW 264 cells. Considering that UKT exhibited the most potent effect, we examined its effect on RANKL-induced osteoclastogenesis, the induction of osteoclast apoptosis, and the mechanisms underlying its effects. UKT inhibits RANKL-induced osteoclast differentiation in the early stage and decreases osteoclast-related genes, including tartrate-resistant acid phosphatase (Trap), dendritic cell-specific transmembrane protein (Dcstamp), matrix metalloproteinase-9 (Mmp9), and cathepsin K (Ctsk). Specifically, UKT inhibits the nuclear factor of activated T cells 1 (NFATc1), which is essential for osteoclastogenesis. UKT increases Bcl6, which antagonizes NFATc1 and Dc-stamp, thereby blocking the progression of osteoclasts to maturation. UKT also decreased nuclear translocation by downregulating the activity of p65/NF-κB. In addition, UKT enhances mononuclear osteoclast apoptosis via activation of caspase-3. Herein, we demonstrate that UKT suppresses RANKL-mediated osteoclastogenesis via the Blimp1–Bcl6 and NF-κB signaling pathways and enhances mononuclear osteoclast apoptosis. Furthermore, UKT prevents bone loss in OVX mice. Thus, UKT might be a potential therapeutic agent for postmenopausal osteoporosis.
Collapse
Affiliation(s)
- Ke Fang
- Department of Hygiene and Public Health, Kansai Medical University, 2-5-1 Shin-machi, Hirakata 573-1010, Japan; (K.F.); (Y.M.); (T.S.); (T.N.)
| | - Yuki Murakami
- Department of Hygiene and Public Health, Kansai Medical University, 2-5-1 Shin-machi, Hirakata 573-1010, Japan; (K.F.); (Y.M.); (T.S.); (T.N.)
- Regenerative Research Center for Intractable Diseases, Kansai Medical University, 2-5-1 Shin-machi, Hirakata 573-1010, Japan
| | - Seiji Kanda
- Department of Hygiene and Public Health, Kansai Medical University, 2-5-1 Shin-machi, Hirakata 573-1010, Japan; (K.F.); (Y.M.); (T.S.); (T.N.)
- Regenerative Research Center for Intractable Diseases, Kansai Medical University, 2-5-1 Shin-machi, Hirakata 573-1010, Japan
- Correspondence: ; Tel.: +81-72-804-2403
| | - Takaki Shimono
- Department of Hygiene and Public Health, Kansai Medical University, 2-5-1 Shin-machi, Hirakata 573-1010, Japan; (K.F.); (Y.M.); (T.S.); (T.N.)
- Regenerative Research Center for Intractable Diseases, Kansai Medical University, 2-5-1 Shin-machi, Hirakata 573-1010, Japan
| | - Anh Tuan Dang
- Department of Molecular Biology and Biochemistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan; (A.T.D.); (M.O.)
- Department of Oral Rehabilitation and Regenerative Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan
| | - Mitsuaki Ono
- Department of Molecular Biology and Biochemistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan; (A.T.D.); (M.O.)
- Department of Oral Rehabilitation and Implantology, Okayama University Hospital, Okayama 700-8558, Japan
| | - Toshimasa Nishiyama
- Department of Hygiene and Public Health, Kansai Medical University, 2-5-1 Shin-machi, Hirakata 573-1010, Japan; (K.F.); (Y.M.); (T.S.); (T.N.)
| |
Collapse
|
3
|
Muthusami S, Vidya B, Shankar EM, Vadivelu J, Ramachandran I, Stanley JA, Selvamurugan N. The Functional Significance of Endocrine-immune Interactions in Health and Disease. Curr Protein Pept Sci 2021; 21:52-65. [PMID: 31702489 DOI: 10.2174/1389203720666191106113435] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2019] [Revised: 09/30/2019] [Accepted: 10/03/2019] [Indexed: 02/06/2023]
Abstract
Hormones are known to influence various body systems that include skeletal, cardiac, digestive, excretory, and immune systems. Emerging investigations suggest the key role played by secretions of endocrine glands in immune cell differentiation, proliferation, activation, and memory attributes of the immune system. The link between steroid hormones such as glucocorticoids and inflammation is widely known. However, the role of peptide hormones and amino acid derivatives such as growth and thyroid hormones, prolactin, dopamine, and thymopoietin in regulating the functioning of the immune system remains unclear. Here, we reviewed the findings pertinent to the functional role of hormone-immune interactions in health and disease and proposed perspective directions for translational research in the field.
Collapse
Affiliation(s)
- Sridhar Muthusami
- Department of Biochemistry, Karpagam Academy of Higher Education, Eachanari, Coimbatore 641021, Tamil Nadu, India
| | - Balasubramanian Vidya
- Department of Biochemistry, Karpagam Academy of Higher Education, Eachanari, Coimbatore 641021, Tamil Nadu, India
| | - Esaki M Shankar
- Department of Life Sciences, School of Life Sciences, Central University of Tamil Nadu, Thiruvarur 610005, India
| | - Jamuna Vadivelu
- Department of Medical Microbiology, Faculty of Medicine, University of Malaya, Lembah Pantai, Kuala Lumpur 50603, Malaysia
| | - Ilangovan Ramachandran
- Department of Endocrinology, Dr. ALM PG Institute of Basic Medical Sciences, University of Madras, Taramani Campus, Chennai 600 113, Tamil Nadu, India
| | - Jone A Stanley
- College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas 77843, United States
| | - Nagarajan Selvamurugan
- Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur 603 203, Tamil Nadu, India
| |
Collapse
|
4
|
Hsiao CY, Chen TH, Chu TH, Ting YN, Tsai PJ, Shyu JF. Calcitonin Induces Bone Formation by Increasing Expression of Wnt10b in Osteoclasts in Ovariectomy-Induced Osteoporotic Rats. Front Endocrinol (Lausanne) 2020; 11:613. [PMID: 33013696 PMCID: PMC7506163 DOI: 10.3389/fendo.2020.00613] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/02/2020] [Accepted: 07/27/2020] [Indexed: 11/13/2022] Open
Abstract
Calcitonin is a small peptide hormone secreted from the parafollicular cells of the thyroid gland in response to an increase in serum calcium. The inhibition of osteoclastic resorption is the main mechanism by which calcitonin quickly decreases circulating calcium levels. Although calcitonin pharmacologically acts on osteoclasts to prevent bone resorption, the results of studies on genetically modified animals have shown that the physiological effect of calcitonin is in the inhibition of osteoblastic bone formation. Because the calcitonin receptor is only expressed in osteoclasts, the effect of calcitonin on osteoblasts maybe indirect and mediated via osteoclasts. Wnt ligands are involved in various aspects of skeletal biology, including bone remodeling and endochondral bone formation. Wnt10b has recently been recognized as a clastokine, and is potentially a therapeutic target for treating bone disorders. However, the extent to which Wnt signaling is involved in bone physiology and disease is not yet fully understood. We hypothesize that calcitonin indirectly increases osteoblastic bone formation by inducing Wnt10b expression in osteoclasts. Micro-CT analysis revealed reduced bone loss in calcitonin-treated ovariectomized rats. The serum of animals treated with calcitonin had decreased TRAP5b and CTX-1 but increased osteocalcin, P1NP, and Wnt10b. Immunohistochemistry staining showed that the level of Wnt10b in the femur was increased in calcitonin-treated groups as compared with control groups. Hematopoietic mononuclear cells were separated from rat femur and tibia bone marrow, and were induced into osteoclasts following treatment with M-CSF and RANKL. In these cells, immunoconfocal microscopy and Western blot analysis showed that calcitonin induced an increase in Wnt10b expression. In a culture of osteoblasts isolated from neonatal rat calvariae, the calcitonin-treated osteoclast supernatant showed an increase in mineralization, as indicated by ALP and alizarin red staining. Taken together, these results indicate that calcitonin induces bone formation by increasing the expression of Wnt10b in osteoclasts in ovariectomy-induced osteoporotic rats. The present study provides in-depth information about the effects of calcitonin on bone remodeling and will thus help in the development of future potential therapeutic strategies for postmenopausal osteoporosis.
Collapse
Affiliation(s)
- Chen-Yuan Hsiao
- National Defense Medical Center, Graduate Institute of Medical Sciences, Taipei, Taiwan
- Department of Surgery, Landseed International Hospital, Taoyuan, Taiwan
| | - Tien-Hua Chen
- School of Medicine, Institute of Anatomy and Cell Biology, National Yang Ming University, Taipei, Taiwan
- Department of Surgery, Trauma Center, Veterans General Hospital, Taipei, Taiwan
- Division of General Surgery, Department of Surgery, Veterans General Hospital, Taipei, Taiwan
| | - Tzu-Hui Chu
- Department of Biology and Anatomy, National Defense Medical Center, Taipei, Taiwan
| | - Yen-Nien Ting
- Department of Biology and Anatomy, National Defense Medical Center, Taipei, Taiwan
| | - Pei-Jiun Tsai
- School of Medicine, Institute of Anatomy and Cell Biology, National Yang Ming University, Taipei, Taiwan
- Department of Surgery, Trauma Center, Veterans General Hospital, Taipei, Taiwan
- Department of Critical Care Medicine, Veterans General Hospital, Taipei, Taiwan
- *Correspondence: Pei-Jiun Tsai
| | - Jia-Fwu Shyu
- Department of Biology and Anatomy, National Defense Medical Center, Taipei, Taiwan
- Department of Psychiatry, National Defense Medical Center, Tri-Service General Hospital, Taipei, Taiwan
- Jia-Fwu Shyu
| |
Collapse
|
5
|
Soysa NS, Alles N. Positive and negative regulators of osteoclast apoptosis. Bone Rep 2019; 11:100225. [PMID: 31720316 PMCID: PMC6838739 DOI: 10.1016/j.bonr.2019.100225] [Citation(s) in RCA: 27] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/19/2019] [Revised: 08/22/2019] [Accepted: 10/02/2019] [Indexed: 12/26/2022] Open
Abstract
Survival and apoptosis are of major importance in the osteoclast life cycle. As osteoclasts have short lifespan, any alteration that prolongs their viability may cause enhanced osteoclast activity. Hence, the regulation of OC apoptosis has been recognized as a critical factor in bone remodeling. An imbalance in bone remodeling due to increased osteoclast activity leads to most adult bone diseases such as osteoporosis, rheumatoid arthritis and multiple myeloma. Therefore, manipulating osteoclast death would be a viable therapeutic approach in ameliorating bone diseases, with accelerated resorption. Over the last few decades we have witnessed the unraveling of many of the intracellular mechanisms responsible for osteoclast apoptosis. Thus, an understanding of the underlying mechanisms by which osteoclasts undergo programmed cell death and the regulators that modulate that activity will undoubtedly provide an insight into the development of pharmacological agents to treat such pathological bone diseases.
Collapse
Affiliation(s)
- Niroshani Surangika Soysa
- Division of Pharmacology, Department of Oral Medicine and Periodontology, Faculty of Dental Sciences, University of Peradeniya, Sri Lanka
| | - Neil Alles
- Department of Biochemistry, Faculty of Medicine, University of Peradeniya, Sri Lanka
| |
Collapse
|
6
|
Zhang LN, Wang XX, Wang Z, Li KY, Xu BH, Zhang J. Berberine improves advanced glycation end products‑induced osteogenic differentiation responses in human periodontal ligament stem cells through the canonical Wnt/β‑catenin pathway. Mol Med Rep 2019; 19:5440-5452. [PMID: 31059099 PMCID: PMC6522873 DOI: 10.3892/mmr.2019.10193] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2018] [Accepted: 04/02/2019] [Indexed: 12/14/2022] Open
Abstract
The aim of the present study was to investigate the effects of advanced glycation end products (AGEs) and berberine hydrochloride (BBR) on the osteogenic differentiation ability of human periodontal ligament stem cells (hPDLSCs) in vitro, and their underlying mechanisms. hPDLSCs were subjected to osteogenic induction and were treated with AGEs or AGEs + BBR. Following varying numbers of days in culture, alkaline phosphatase (ALP) activity assays, ALP staining, alizarin red staining, ELISAs, and reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) and western blot analyses were performed to determine the osteogenic differentiation ability of hPDLSCs; RT‑qPCR, western blot analysis, and immunofluorescence staining were conducted to investigate the underlying mechanisms. The canonical Wnt/β‑catenin pathway inhibitor XAV‑939 and agonist CHIR‑99021 were used to determine the contribution of the canonical Wnt/β‑catenin pathway to differentiation. Treatment with AGEs resulted in reduced ALP activity and Collagen I protein levels, decreased ALP staining, fewer mineralized nodules, and downregulated expression of osteogenic‑specific genes [Runt‑related transcription factor 2 (Runx2), Osterix, ALP, osteopontin (OPN), Collagen I and osteocalcin (OCN)] and proteins (Runx2, OPN, BSP and OCN); however, BBR partially rescued the AGE‑induced decrease in the osteogenic potential of hPDLSCs. Furthermore, AGEs activated the canonical Wnt/β‑catenin signaling pathway and promoted the nuclear translocation of β‑catenin; BBR partially attenuated this effect. In addition, XAV‑939 partially rescued the AGE‑induced reduction in the osteogenic potential of hPDLSCs, whereas CHIR‑99021 suppressed the BBR‑induced increase in the osteogenic potential of hPDLSCs. The present study indicated that AGEs attenuated the osteogenic differentiation ability of hPDLSCs, in part by activating the canonical Wnt/β‑catenin pathway; however, BBR attenuated these effects by inhibiting the canonical Wnt/β‑catenin pathway. These findings suggest a role for BBR in periodontal regeneration induced by hPDLSCs in patients with diabetes mellitus.
Collapse
Affiliation(s)
- Li-Na Zhang
- Shandong Provincial Key Laboratory of Oral Tissue Regeneration, School of Stomatology, Shandong University, Jinan, Shandong 250012, P.R. China
- Department of Orthodontics, School of Stomatology, Shandong University, Jinan, Shandong 250012, P.R. China
- Department of Orthodontics, Faculty of Stomatology, Liaocheng People's Hospital, Liaocheng, Shandong 252000, P.R. China
| | - Xu-Xia Wang
- Shandong Provincial Key Laboratory of Oral Tissue Regeneration, School of Stomatology, Shandong University, Jinan, Shandong 250012, P.R. China
- Department of Oral and Maxillofacial Surgery, School of Stomatology, Shandong University, Jinan, Shandong 250012, P.R. China
| | - Zhi Wang
- Department of Orthodontics, Faculty of Stomatology, Linyi People's Hospital of Shandong, Linyi, Shandong 276000, P.R. China
| | - Ke-Yi Li
- Department of Oral and Maxillofacial Surgery, Faculty of Stomatology, Liaocheng People's Hospital, Liaocheng, Shandong 252000, P.R. China
| | - Bao-Hua Xu
- Dental Medical Center, China-Japan Friendship Hospital, Ministry of Health, Chaoyang, Beijing 100029, P.R. China
| | - Jun Zhang
- Shandong Provincial Key Laboratory of Oral Tissue Regeneration, School of Stomatology, Shandong University, Jinan, Shandong 250012, P.R. China
- Department of Orthodontics, School of Stomatology, Shandong University, Jinan, Shandong 250012, P.R. China
| |
Collapse
|
7
|
Chen CH, Chen WC, Lin CY, Chen CH, Tsuang YH, Kuo YJ. Sintered dicalcium pyrophosphate treatment attenuates estrogen deficiency-associated disc degeneration in ovariectomized rats. DRUG DESIGN DEVELOPMENT AND THERAPY 2018; 12:3033-3041. [PMID: 30271118 PMCID: PMC6151093 DOI: 10.2147/dddt.s170816] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
Background Estrogen deficiency is associated with musculoskeletal disorders. Sintered dicalcium pyrophosphate (SDCP) is a novel antiosteoporotic agent. In this study, we examined its use for restoration of bone quality and attenuation of disc degeneration in ovariectomy rats. Methods Sixty female Sprague Dawley rats were randomly divided into 3 groups, namely sham group undergoing sham surgery, ovariectomy (OVX) group receiving an equivalent volume of isotonic sodium chloride solution, and OVX/SDCP group orally administered with 0.25 mg/mL SDCP. Animals were sacrificed at 3 and 6 months post ovariectomy and lumbar vertebrae and intervertebral discs were harvested. Bone mineral density, micro-computed tomography analysis, and biomechanical testing were performed to assess bone quality. Histological analysis with hematoxylin and eosin, Alcian blue, and Masson’s trichrome stain were conducted to determine disc degeneration. Immunohistochemistry and real-time PCR were carried out to measure the expressions of aggrecan, type I collagen, type II collagen, and MMP-1, MMP-3, and MMP-13. Results SDCP improved bone quality as observed by the results of increased bone mineral density and stiffness in OVX rats. The improvement in disc degeneration induced by estrogen withdrawal was associated with reduced gene expressions of MMPs and increased production of collagen type II. Conclusion SDCP prevents osteoporosis and ameliorates disc degeneration in OVX rats. It represents a favorable therapeutic agent for osteoporotic and osteoarthritic conditions in clinical practice.
Collapse
Affiliation(s)
- Chia-Hsien Chen
- Department of Orthopedics, Shuang Ho Hospital, Taipei Medical University, New Taipei, Taiwan.,Department of Orthopedic Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, .,School of Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan
| | - Wei-Chuan Chen
- Graduate School of Biotechnology and Bioengineering, Yuan Ze University, Taoyuan City, Taiwan
| | - Chun-Yi Lin
- Department of Orthopedic Surgery, Taipei Medical University Hospital, Taipei, Taiwan
| | - Chih-Hwa Chen
- Department of Orthopedics, Shuang Ho Hospital, Taipei Medical University, New Taipei, Taiwan.,Department of Orthopedic Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, .,School of Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan
| | - Yang-Hwei Tsuang
- Department of Orthopedics, Shuang Ho Hospital, Taipei Medical University, New Taipei, Taiwan.,Department of Orthopedic Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan,
| | - Yi-Jie Kuo
- Department of Orthopedic Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, .,Department of Orthopedic Surgery, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan,
| |
Collapse
|
8
|
Wang JW, Yeh CB, Chou SJ, Lu KC, Chu TH, Chen WY, Chien JL, Yen MH, Chen TH, Shyu JF. YC-1 alleviates bone loss in ovariectomized rats by inhibiting bone resorption and inducing extrinsic apoptosis in osteoclasts. J Bone Miner Metab 2018; 36:508-518. [PMID: 28983668 DOI: 10.1007/s00774-017-0866-z] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/16/2017] [Accepted: 08/24/2017] [Indexed: 12/27/2022]
Abstract
Osteoporosis is a major health problem in postmenopausal women and the elderly that leads to fractures associated with substantial morbidity and mortality. Current osteoporosis therapies have significant drawbacks, and the risk of fragility fractures has not yet been eliminated. There remains an unmet need for a broader range of therapeutics. Previous studies have shown that YC-1 has important regulatory functions in the cardiovascular and nervous systems. Many of the YC-1 effector molecules in platelets, smooth muscle cells and neurons, such as cGMP and μ-calpain, also have important functions in osteoclasts. In this study, we explored the effects of YC-1 on bone remodeling and determined the potential of YC-1 as a treatment for postmenopausal osteoporosis. Micro-computed tomography of lumbar vertebrae showed that YC-1 significantly improved trabecular bone microarchitecture in ovariectomized rats compared with sham-operated rats. YC-1 also significantly reversed the increases in serum bone resorption and formation in these rats, as measured by enzyme immunoassays for serum CTX-1 and P1NP, respectively. Actin ring and pit formation assays and TRAP staining analysis showed that YC-1 inhibited osteoclast activity and survival. YC-1 induced extrinsic apoptosis in osteoclasts by activating caspase-3 and caspase-8. In osteoclasts, YC-1 stimulated μ-calpain activity and inhibited Src activity. Our findings provide proof-of-concept for YC-1 as a novel antiresorptive treatment strategy for postmenopausal osteoporosis, confirming an important role of nitric oxide/cGMP/protein kinase G signaling in bone.
Collapse
Affiliation(s)
- Jin-Wen Wang
- Department of Orthopedics, Chiali Hospital, Chi Mei Medical Center, Chiali, Taiwan, ROC
| | - Chin-Bin Yeh
- Department of Psychiatry, National Defense Medical Center, Tri-Service General Hospital, Taipei, Taiwan, ROC
| | - Shao-Jiun Chou
- Department of General Surgery, Cardinal Tien Hospital, School of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan, ROC
| | - Kuo-Cheng Lu
- Department of Medicine, Cardinal Tien Hospital, School of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan, ROC
| | - Tzu-Hui Chu
- Department of Biology and Anatomy, National Defense Medical Center, 161 Ming Chuan E. Road Section 6, Taipei, 114, Taiwan, ROC
| | - Wei-Yu Chen
- Department of Biology and Anatomy, National Defense Medical Center, 161 Ming Chuan E. Road Section 6, Taipei, 114, Taiwan, ROC
| | - Jui-Lin Chien
- Department of Biology and Anatomy, National Defense Medical Center, 161 Ming Chuan E. Road Section 6, Taipei, 114, Taiwan, ROC
| | - Mao-Hsiung Yen
- Department of Pharmacology, National Defense Medical Center, Taipei, Taiwan, ROC
| | - Tien-Hua Chen
- Institute of Anatomy and Cell Biology, School of Medicine, National Yang Ming University, Taipei, Taiwan, ROC
| | - Jia-Fwu Shyu
- Department of Biology and Anatomy, National Defense Medical Center, 161 Ming Chuan E. Road Section 6, Taipei, 114, Taiwan, ROC.
| |
Collapse
|
9
|
Cho CS, Jeong HS, Kim IY, Jung GW, Ku BH, Park DC, Moon SB, Cho HR, Ku SK, Choi JS. Antiosteoporotic effects of 3:1 (g/g) mixed formulation of exopolymers purified fromAureobasidium pullulansSM-2001 andDendropanax morbiferaleaf extracts in ovariectomized rats. J Food Biochem 2018. [DOI: 10.1111/jfbc.12548] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Affiliation(s)
- Chang-Soo Cho
- Hurim Hwangchil Co., Ltd., 907-11, Gyeongseo-dearo, Hoengcheon-myeon; Hadong-gun Gyeongsangnam-do 52320 Republic of Korea
| | - Hye-Seong Jeong
- Hurim Hwangchil Co., Ltd., 907-11, Gyeongseo-dearo, Hoengcheon-myeon; Hadong-gun Gyeongsangnam-do 52320 Republic of Korea
| | - In-Young Kim
- Hurim Hwangchil Co., Ltd., 907-11, Gyeongseo-dearo, Hoengcheon-myeon; Hadong-gun Gyeongsangnam-do 52320 Republic of Korea
| | - Go-Woon Jung
- Glucan Corp., #305 Marine Bio-Industry Development Center, 7 Hoenggye-gil; Busan 46048 Republic of Korea
| | - Bon-Hwa Ku
- Glucan Corp., #305 Marine Bio-Industry Development Center, 7 Hoenggye-gil; Busan 46048 Republic of Korea
| | - Dong-Chan Park
- Glucan Corp., #305 Marine Bio-Industry Development Center, 7 Hoenggye-gil; Busan 46048 Republic of Korea
| | - Seung-Bae Moon
- Glucan Corp., #305 Marine Bio-Industry Development Center, 7 Hoenggye-gil; Busan 46048 Republic of Korea
| | - Hyung-Rae Cho
- Glucan Corp., #305 Marine Bio-Industry Development Center, 7 Hoenggye-gil; Busan 46048 Republic of Korea
| | - Sae Kwang Ku
- Department of Anatomy and Histology, College of Korean Medicine; Daegu Haany University, 1, Hanuidae-ro; Gyeongsan-si Gyeongsangbuk-do 38610 Republic of Korea
| | - Jae-Suk Choi
- Major in Food Biotechnology, Division of Bioindustry, College of Medical and Life Sciences; Silla University, 140, Baegyang-daero 700beon-gil; Busan 46958 Republic of Korea
| |
Collapse
|
10
|
Hong J, Wang T, Chen Z, Pan H, Pan X. Rabbit model of subchondral bone bruise and the treatment potential of calcitonin. Am J Transl Res 2017; 9:5603-5610. [PMID: 29312512 PMCID: PMC5752910] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2017] [Accepted: 09/03/2017] [Indexed: 06/07/2023]
Abstract
BACKGROUND This study characterized a novel rabbit model of subchondral bone bruise and investigated the intervening effect of calcitonin. METHODS Bone bruise was implemented via controlled free-fall counterpoise on the medial tibial subchondral bone of 5-month-old New Zealand rabbits, with 3, 2.5, or 2 Joules of energy. Subsequent subchondral bone bruise was characterized via magnetic resonance imaging, micro computed tomography, and histology. Calcitonin was administered for 3 weeks, and the changes in subchondral bone were characterized. RESULTS The severity of subchondral bone bruise lesions correlated with the energy applied. The lesions involved trabecular separation and reduced trabecular number, with bone marrow edema and trabecular micro-fracture. With calcitonin treatment, subchondral bone marrow edema subsided and trabecular ultrastructure repaired. CONCLUSION Free fall counterpoise is a promising method to establish a subchondral bone bruise model in rabbits. Calcitonin injection is a potential treatment for subchondral bone bruise lesions.
Collapse
Affiliation(s)
- Jinsong Hong
- Department of Orthopedic and Traumatology, Guangzhou Orthopedic HospitalGuangzhou, China
| | - Ting Wang
- Center for Human Tissue and Organ Degeneration and Shenzhen Key Laboratory of Marine Biomedical Materials, Shenzhen Institutes of Advanced Technology, China Academy of ScienceShenzhen, China
| | - Zhibin Chen
- Department of Orthopedics and Traumatology, Bao’an Hospital Affiliated to Southern Medical University and Shenzhen Eighth People’s HospitalShenzhen 518100, China
| | - Haobo Pan
- Center for Human Tissue and Organ Degeneration and Shenzhen Key Laboratory of Marine Biomedical Materials, Shenzhen Institutes of Advanced Technology, China Academy of ScienceShenzhen, China
| | - Xiaohua Pan
- Department of Orthopedics and Traumatology, Bao’an Hospital Affiliated to Southern Medical University and Shenzhen Eighth People’s HospitalShenzhen 518100, China
| |
Collapse
|
11
|
Tsai YF, Hsu LH, Wu CC, Cai WH, Yang KC, Fan FY. Long-Term Oral Toxicity and Anti-osteoporotic Effect of Sintered Dicalcium Pyrophosphate in Rat Model of Postmenopausal Osteoporosis. J Med Biol Eng 2017; 37:181-190. [PMID: 29930493 PMCID: PMC5990578 DOI: 10.1007/s40846-016-0197-x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2015] [Accepted: 04/07/2016] [Indexed: 11/29/2022]
Abstract
Sintered dicalcium pyrophosphate (SDCP), a synthetic pyrophosphate analog, has shown potential for the management of osteoporosis. The long-term oral toxicity and anti-osteoporotic effect of SDCP in a postmenopausal osteoporosis rat model were evaluated in this study. SDCP was orally administered to bilateral ovariectomized (OVX) Wistar rats at a dose of 0.75 mg/kg daily for 24 weeks following by 2 weeks of observation. There were no abnormal findings in clinical signs of toxicity, food consumption, body weight, blood examination, necropsy, and histological inspection attributable to the ingestion of SDCP. The serum level of type I collagen fragments, a bone resorption marker, decreased in SDCP-treated rats, and the bone formation markers alkaline phosphatase, osteocalcin, and osteopontin significantly decreased. These findings indicate that the bone turnover rate decreased in SDCP-treated animals. Relative to OVX rats, the increase in serum tartrate-resistant acid phosphatase 5b level represents an increase in bony tissues in the SDCP-treated rats. Histological examinations of distal femoral metaphyses further revealed that the ingestion of SDCP improved the trabecular bone architecture and decreased bone porosity. Analysis of limb bone ashes showed a significant increase in bone mineral content. Our results show that SDCP inhibits bone resorption to restore bone mass in OVX rats without deleterious effects, and therefore that SDCP has potential in the management of osteoporosis.
Collapse
Affiliation(s)
- Yuh-Feng Tsai
- 1Department of Diagnostic Radiology, Shin-Kong Wu Ho-Su Memorial Hospital, Taipei City, 111 Taiwan.,2School of Medicine, Fu-Jen Catholic University, New Taipei City, 24205 Taiwan
| | - Li-Ho Hsu
- 3Department of Orthopedics, En Chu Kong Hospital, New Taipei City, 23702 Taiwan.,4Department of Orthopedics, College of Medicine, National Taiwan University Hospital, National Taiwan University, Taipei City, 10002 Taiwan
| | - Chang-Chin Wu
- 3Department of Orthopedics, En Chu Kong Hospital, New Taipei City, 23702 Taiwan.,4Department of Orthopedics, College of Medicine, National Taiwan University Hospital, National Taiwan University, Taipei City, 10002 Taiwan.,5Department of Biomedical Engineering, Yuanpei University of Medical Technology, Hsinchu, 30015 Taiwan
| | - Wei-Hua Cai
- 6School of Dental Technology, College of Oral Medicine, Taipei Medical University, 250 Wu-Hsing Street, Taipei City, 11031 Taiwan
| | - Kai-Chiang Yang
- 6School of Dental Technology, College of Oral Medicine, Taipei Medical University, 250 Wu-Hsing Street, Taipei City, 11031 Taiwan
| | - Fang-Yu Fan
- 6School of Dental Technology, College of Oral Medicine, Taipei Medical University, 250 Wu-Hsing Street, Taipei City, 11031 Taiwan
| |
Collapse
|
12
|
Li S, Zhang W, Duan F, Liu W, Sun X, Pan X. The preventive and therapeutic roles of phytoestrogen α-Zearalanol on osteoporetic rats due to ovariectomization. IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES 2016; 19:1216-1221. [PMID: 27917278 PMCID: PMC5126223] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
OBJECTIVES The aim of this study was to observe the influence of phytoestrogen α-Zearalanol on ovariectomy-induced postmenopausal osteoporosis in rats. MATERIALS AND METHODS 40 SD female rats were randomly divided into four groups: Sham group, OVX group (ovariectomized and fed estrogen), α-Zearalanol group (ovariectomized and fed α-Zearalanol) and untreated group (ovariectomized). Three weeks later after surgery, α-Zearalanol and estradiol valerate were administered by oral gavage for 12 weeks to the α-Zearalanol group and the OVX group, respectively. In contrast, the sham and untreated controls were treated with distilled water in a daily basis. After the treatments, uterus histomorphometry, bone mechanical strength, bone histomorphometry, bone mineral density (BMD) of femur, and serum biochemical indicators, such as serum E2, CT and PTH, as well as the levels of TNF and IL-1 were examined. RESULTS The BMD was overall declined rigorously in the OVX rats, and that could be mitigated through feeding on either estrogen or α-Zearalanol. Estrogen or α-Zearalanol was found to decrease the levels of serum ALP and BGP in OVX rats, while, α-Zearalanol was found to increase the levels of serum E2 and CT, the thickness of the endometrium, and decrease the levels of PTH, TNF and IL-1 in serum in OVX rats. Feeding the OVX rats on α-Zearalanol improved the bone histomorphometric parameters impaired due to estrogen deficiency and enhanced the bone mechanical properties in the ovariectomized rats. CONCLUSION α-Zearalanol treated rats reduced the resorption of bone, and showed a preventive and therapeutic effect of α-Zearalanol on postmenopausal osteoporosis.
Collapse
Affiliation(s)
- Shaochun Li
- School of Basic Medical Sciences, Hebei University, Baoding 071002, China,Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China
| | - Weiwei Zhang
- School of Basic Medical Sciences, Hebei University, Baoding 071002, China
| | - Fei Duan
- School of Basic Medical Sciences, Hebei University, Baoding 071002, China
| | - Weihua Liu
- School of Basic Medical Sciences, Hebei University, Baoding 071002, China
| | - Xiaofang Sun
- School of Basic Medical Sciences, Hebei University, Baoding 071002, China
| | - Xuefeng Pan
- School of Basic Medical Sciences, Hebei University, Baoding 071002, China,School of Life Science, Beijing Institute of Technology, Beijing 10081, China,Corresponding author: Xuefeng Pan. School of Basic Medical Sciences, Hebei University, Baoding 071002, China, School of Life Science, Beijing Institute of Technology, Beijing 10081, China. Tel: +86-1068914495;
| |
Collapse
|
13
|
Yeh CB, Weng SJ, Chang KW, Chan JYH, Huang SM, Chu TH, Wei NK, Ma HS, Cheng JT, Ma KH, Chen TH, Shyu JF. Calcitonin alleviates hyperalgesia in osteoporotic rats by modulating serotonin transporter activity. Osteoporos Int 2016; 27:3355-3364. [PMID: 27260496 DOI: 10.1007/s00198-016-3652-1] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/06/2015] [Accepted: 05/24/2016] [Indexed: 02/03/2023]
Abstract
UNLABELLED Calcitonin may relieve pain by modulating central serotonin activity. Calcitonin partly reversed the hypersensitivity to pain induced by ovariectomy. This suggests that the anti-nociceptive effects of calcitonin in the treatment of osteoporosis may be mediated by alterations in neural serotonin transporter (SERT) activity. INTRODUCTION This study used a rat model of osteoporosis to evaluate the role of the cerebral serotonin system in the anti-nociceptive effect of calcitonin, a drug used to treat post-menopausal osteoporosis. METHODS Osteoporosis was induced in rats by ovariectomy (OVX). Rats were then randomized to the following four groups: sham operation, OVX, OVX plus calcitonin, or OVX plus alendronate. RESULTS OVX led to alterations in bone micro-architecture; alendronate strongly reversed this effect, and calcitonin moderately reversed this effect. OVX increased hyperalgesia (determined as the time for hind paw withdrawal from a heat source); calcitonin reduced this effect, but alendronate had no effect. OVX increased the expression of c-Fos (a neuronal marker of pain) in the thalamus; calcitonin strongly reversed this effect, and alendronate moderately reversed this effect. OVX also reduced SERT but increased 5-HT1A receptor expression and activity; calcitonin aggravated this effect, but alendronate had no effect on recovery of SERT/5-HT1A activity and expression. CONCLUSIONS Our study of a rat model of osteoporosis suggests that OVX-induced enhancement of the serotonergic system may protect against hyperalgesia. However, the anti-nociceptive effects of calcitonin in osteoporosis may be mediated by decreased neural SERT activity and increased activation of 5-HT1 receptors in the thalamus.
Collapse
Affiliation(s)
- C-B Yeh
- Department of Psychiatry, National Defense Medical Center, Tri-Service General Hospital, Taipei, Taiwan
| | - S-J Weng
- Department of Biology and Anatomy, National Defense Medical Center, 161 Ming Chuan E. Road Section 6, Taipei, Taiwan, 114, People's Republic of China
| | - K-W Chang
- Atomic Energy Council, Executive Yuan, Institute of Nuclear Energy Research, Taoyuan, Taiwan
| | - J Y-H Chan
- Graduate Institute of Life Science, National Defense Medical Center, Taipei, Taiwan
| | - S-M Huang
- Department of Biochemistry, National Defense Medical Center, Taipei, Taiwan
| | - T-H Chu
- Department of Biology and Anatomy, National Defense Medical Center, 161 Ming Chuan E. Road Section 6, Taipei, Taiwan, 114, People's Republic of China
| | - N-K Wei
- Department of Biology and Anatomy, National Defense Medical Center, 161 Ming Chuan E. Road Section 6, Taipei, Taiwan, 114, People's Republic of China
| | - H-S Ma
- Department of Biology and Anatomy, National Defense Medical Center, 161 Ming Chuan E. Road Section 6, Taipei, Taiwan, 114, People's Republic of China
| | - J-T Cheng
- Department of Biology and Anatomy, National Defense Medical Center, 161 Ming Chuan E. Road Section 6, Taipei, Taiwan, 114, People's Republic of China
| | - K-H Ma
- Department of Biology and Anatomy, National Defense Medical Center, 161 Ming Chuan E. Road Section 6, Taipei, Taiwan, 114, People's Republic of China
| | - T-H Chen
- School of Medicine, Institute of Anatomy and Cell Biology, National Yang Ming University, Taipei, Taiwan
- Department of Surgery, Veteran General Hospital, Taipei, Taiwan
| | - J-F Shyu
- Department of Biology and Anatomy, National Defense Medical Center, 161 Ming Chuan E. Road Section 6, Taipei, Taiwan, 114, People's Republic of China.
| |
Collapse
|
14
|
Furness S, Hare DL, Kourakis A, Turnley AM, Wookey PJ. A novel ligand of calcitonin receptor reveals a potential new sensor that modulates programmed cell death. Cell Death Discov 2016; 2:16062. [PMID: 27777788 PMCID: PMC5056446 DOI: 10.1038/cddiscovery.2016.62] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2016] [Revised: 06/14/2016] [Accepted: 07/14/2016] [Indexed: 11/24/2022] Open
Abstract
We have discovered that the accumulation of an anti-calcitonin receptor (anti-CTR) antibody conjugated to a fluorophore (mAb2C4:AF568) provides a robust signal for cells undergoing apoptotic programmed cell death (PCD). PCD is an absolute requirement for normal development of metazoan organisms. PCD is a hallmark of common diseases such as cardiovascular disease and tissue rejection in graft versus host pathologies, and chemotherapeutics work by increasing PCD. This robust signal or high fluorescent events were verified by confocal microscopy and flow cytometry in several cell lines and a primary culture in which PCD had been induced. In Jurkat cells, GBM-L2 and MG63 cells, the percentage undergoing PCD that were positive for both mAb2C4:AF568 and annexin V ranged between 70 and >90%. In MG63 cells induced for the preapoptotic cell stress response (PACSR), the normal expression of α-tubulin, a key structural component of the cytoskeleton, and accumulation of mAb2C4:AF568 were mutually exclusive. Our data support a model in which CTR is upregulated during PACSR and recycles to the plasma membrane with apoptosis. In cells committed to apoptosis (α-tubulin negative), there is accumulation of the CTR-ligand mAb2C4:AF568 generating a high fluorescent event. The reagent mAb2C4:AF568 effectively identifies a novel event linked to apoptosis.
Collapse
Affiliation(s)
- Sgb Furness
- Drug Discovery Biology Laboratory, Monash Institute of Pharmaceutical Science, 381 Royal Parade, Parkville, Victoria 3052, Australia; Department of Pharmacology, Monash University, Wellington Road, Clayton, Parkville, Victoria 3800, Australia
| | - D L Hare
- Department of Medicine, University of Melbourne, Austin Health , Level 7, Lance Townsend Building, Studley Road, Heidelberg, Victoria 3084, Australia
| | - A Kourakis
- Department of Medicine, University of Melbourne, Austin Health , Level 7, Lance Townsend Building, Studley Road, Heidelberg, Victoria 3084, Australia
| | - A M Turnley
- Department of Anatomy and Neuroscience, Melbourne Brain Centre, University of Melbourne , Royal Parade, Parkville, Victoria 3010, Australia
| | - P J Wookey
- Department of Medicine, University of Melbourne, Austin Health , Level 7, Lance Townsend Building, Studley Road, Heidelberg, Victoria 3084, Australia
| |
Collapse
|
15
|
Wu VM, Uskoković V. Is there a relationship between solubility and resorbability of different calcium phosphate phases in vitro? BIOCHIMICA ET BIOPHYSICA ACTA 2016; 1860:2157-68. [PMID: 27212690 PMCID: PMC4961619 DOI: 10.1016/j.bbagen.2016.05.022] [Citation(s) in RCA: 29] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/19/2016] [Revised: 05/01/2016] [Accepted: 05/17/2016] [Indexed: 10/21/2022]
Abstract
BACKGROUND Does chemistry govern biology or it is the other way around - that is a broad connotation of the question that this study attempted to answer. METHOD Comparison was made between the solubility and osteoclastic resorbability of four fundamentally different monophasic calcium phosphate (CP) powders with monodisperse particle size distributions: alkaline hydroxyapatite (HAP), acidic monetite (DCP), β-calcium pyrophosphate (CPP), and amorphous CP (ACP). Results With the exception of CPP, the difference in solubility between different CP phases became neither mitigated nor reversed, but augmented in the resorptive osteoclastic milieu. Thus, DCP, a phase with the highest solubility, was also resorbed more intensely than any other CP phase, whereas HAP, a phase with the lowest solubility, was resorbed least. CPP becomes retained inside the cells for the longest period of time, indicating hindered digestion of only this particular type of CP. Osteoclastogenesis was mildly hindered in the presence of HAP, ACP and DCP, but not in the presence of CPP. The most viable CP powder with respect to the mitochondrial succinic dehydrogenase activity was the one present in natural biological bone tissues: HAP. CONCLUSION Chemistry in this case does have a direct effect on biology. Biology neither overrides nor reverses the chemical propensities of inorganics with which it interacts, but rather augments and takes a direct advantage of them. SIGNIFICANCE These findings set the fundamental basis for designing the chemical makeup of CP and other biosoluble components of tissue engineering constructs for their most optimal resorption and tissue regeneration response.
Collapse
Affiliation(s)
- Victoria M Wu
- Advanced Materials and Nanobiotechnology Laboratory, Department of Bioengineering, University of Illinois, Chicago, IL, USA
| | - Vuk Uskoković
- Advanced Materials and Nanobiotechnology Laboratory, Department of Bioengineering, University of Illinois, Chicago, IL, USA
| |
Collapse
|
16
|
Dried pomegranate potentiates anti-osteoporotic and anti-obesity activities of red clover dry extracts in ovariectomized rats. Nutrients 2015; 7:2622-47. [PMID: 25912038 PMCID: PMC4425164 DOI: 10.3390/nu7042622] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2015] [Revised: 03/10/2015] [Accepted: 04/02/2015] [Indexed: 12/19/2022] Open
Abstract
Red clover (RC) shows potential activity against menopausal symptoms and pomegranates have antioxidative and beneficial effects on postmenopausal symptoms; thus, we investigated whether the anti-climacteric activity of RC could be enhanced by the addition of dried pomegranate concentrate powder (PCP) extracts in ovariectomized (OVX) rats. Regarding the anti-osteoporotic effects, bone mineral density increased significantly in OVX induced rats treated with 60 and 120 mg/kg of an RC:PCP 2:1 mixture, respectively, compared with OVX control rats. Additionally, femoral, tibia, and L4 bone resorption was decreased in OVX induced control rats treated with the RC:PCP 2:1 mixture (60 and 120 mg/kg), respectively, compared with OVX control rats. Regarding anti-obesity effects, the OVX induced rats treated with 60 and 120 mg/kg of the RC:PCP 2:1 mixture showed a decrease in total fat pad thickness, the mean diameters of adipocytes and the body weights gain compared with OVX induced control rats. The estradiol and bone-specific alkaline phosphatase levels were significantly increased in OVX induced rats treated with the RC:PCP 2:1 mixture (120 mg/kg) compared with OVX induced control rats, also, the uterine atrophy was significantly inhibited in 60 and 120 mg/kg of the RC:PCP 2:1 mixture treatment compared with OVX control rats. In conclusion, our results indicate that PCP enhanced the anti-climacteric effects of RC in OVX rats. The RC:PCP 2:1 mixture used in this study may be a promising new potent and protective agent for relieving climacteric symptoms.
Collapse
|
17
|
Liu X, Liu Y, Cheng M, Zhang X, Xiao H. A metabolomics study of the inhibitory effect of 17-beta-estradiol on osteoclast proliferation and differentiation. MOLECULAR BIOSYSTEMS 2014; 11:635-46. [PMID: 25474166 DOI: 10.1039/c4mb00528g] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
Estradiol is a major drug used clinically to alleviate osteoporosis, partly through inhibition of the activity of osteoclasts, which play a crucial role in bone resorption. So far, little is known about the effects of estradiol on osteoclast metabolism. In this study, ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC/MS)-based metabolomics strategy was used to investigate the metabolite response to 17β-estradiol in mouse osteoclast RAW264.7, a commonly used cell model for studying osteoporosis. Our results showed that the application of estradiol altered the levels of 27 intracellular metabolites, including lysophosphatidylcholines (LysoPCs), other lipids and amino acid derivants. The changes of all the 27 metabolites were observed in the study of estradiol induced osteoclast proliferation inhibition (1 μM estradiol applied), while the changes of only 18 metabolites were observed in the study of differentiation inhibition (0.1 μM estradiol applied). Further pathway impact analysis determined glycerophospholipid metabolism as the main potential target pathway of estradiol, which was further confirmed by LCAT (phosphatidylcholine-sterol acyltransferase) activity changes and lipid peroxidative product (MDA, methane dicarboxylic aldehyde) changes caused by estradiol. Additionally, we found that estradiol significantly decreased intracellular oxidative stress during cell proliferation but not during cell differentiation. Our study suggested that estradiol generated a highly condition-dependent influence on osteoclast metabolism.
Collapse
Affiliation(s)
- Xiaoyan Liu
- Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Science, Dalian 116023, China.
| | | | | | | | | |
Collapse
|
18
|
Preventive effects of collagen Peptide from deer sinew on bone loss in ovariectomized rats. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE 2014; 2014:627285. [PMID: 25101135 PMCID: PMC4102020 DOI: 10.1155/2014/627285] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/02/2014] [Accepted: 06/10/2014] [Indexed: 01/22/2023]
Abstract
Deer sinew (DS) has been used traditionally for various illnesses, and the major active constituent is collagen. In this study, we assessed the effects of collagen peptide from DS on bone loss in the ovariectomized rats. Wister female rats were randomly divided into six groups as follows: sham-operated (SHAM), ovariectomized control (OVX), OVX given 1.0 mg/kg/week nylestriol (OVX + N), OVX given 0.4 g/kg/day collagen peptide (OVX + H), OVX given 0.2 g/kg/day collagen peptide (OXV + M), and OVX given 0.1 g/kg/day collagen peptide (OXV + L), respectively. After 13 weeks of treatment, the rats were euthanized, and the effects of collagen peptide on body weight, uterine weight, bone mineral density (BMD), serum biochemical indicators, bone histomorphometry, and bone mechanics were observed. The data showed that BMD and concentration of serum hydroxyproline were significantly increased and the levels of serum calcium, phosphorus, and alkaline phosphatase were decreased. Besides, histomorphometric parameters and mechanical indicators were improved. However, collagen peptide of DS has no effect on estradiol level, body weight, and uterine weight. Therefore, these results suggest that the collagen peptide supplementation may also prevent and treat bone loss.
Collapse
|
19
|
Kuo YJ, Sun JS, Rau G, Chen CH, Tsai TH, Tsuang YH. Better Osteoporotic Fracture Healing with Sintered Dicalcium Pyrophosphate (SDCP) Treatment: A Rat Femoral Fracture Model. J Histochem Cytochem 2014; 62:565-76. [PMID: 24828625 DOI: 10.1369/0022155414538264] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2013] [Accepted: 04/24/2014] [Indexed: 01/08/2023] Open
Abstract
The aim of this study was to evaluate the effect of sintered dicalcium pyrophosphate (SDCP) on fracture healing in an osteoporotic rat model. Female Sprague-Dawley rats (8 weeks old) were randomly allocated into five groups: sham-operated group, and bilateral ovariectomized group treated with SDCP, alendronate, calcitonin, or no treatment. Rats were sacrificed at 6 or 16 weeks after fracture. Fracture sites were examined by microcomputed tomography (microCT), histology, and mechanical testing. The results showed that SDCP mildly suppressed callus remodeling at 6 weeks, but not at 16 weeks. The lamellar bone in the callus area and new cortical shell formation in SDCP-treated group were similar to that of the sham group at 16 weeks after fracture, indicating there was no delayed callus remodeling into lamellar bone. At both 6 and 16 weeks after fracture, ultimate stress and elastic modulus were similar between the SDCP and sham groups, and the mechanical strength in these groups was better than that in other groups. Finally, analysis of the serum bone markers CTX-1 and P1NP suggested that SDCP decreased the bone turnover rate and promoted proper fracture healing. The effect of SDCP is superior to that of alendronate and calcitonin in the healing of osteoporotic fractures.
Collapse
Affiliation(s)
- Yi-Jie Kuo
- Institute of Clinical Medicine (YJK, JSS) National Yang Ming University, Taipei, TaiwanInstitute of Microbiology and Immunology (CHC) National Yang Ming University, Taipei, TaiwanInstitute of Traditional Medicine (THT, YHT) National Yang Ming University, Taipei, TaiwanDepartment of Orthopaedics (YJK), School of Medicine, College of MedicineGraduate Institute of Clinical Medicine (JSS, GR), School of Medicine, College of MedicineDepartment of Orthopaedics, Shang-Ho Hospital (GR, CHC, YHT) Taipei Medical University, Taipei, TaiwanDepartment of Orthopaedic Surgery, National Taiwan University Hospital Hsin Chu Branch, Hsin-Chu, Taiwan (JSS)Department of Orthopaedics, Shang-Ho Hospital (CHC, GR, YHT)Department of Orthopaedics, School of Medicine, National Taiwan University Hospital Hsin Chu Branch, Hsin-Chu, Taiwan (JSS)
| | - Jui-Sheng Sun
- Institute of Clinical Medicine (YJK, JSS) National Yang Ming University, Taipei, TaiwanInstitute of Microbiology and Immunology (CHC) National Yang Ming University, Taipei, TaiwanInstitute of Traditional Medicine (THT, YHT) National Yang Ming University, Taipei, TaiwanDepartment of Orthopaedics (YJK), School of Medicine, College of MedicineGraduate Institute of Clinical Medicine (JSS, GR), School of Medicine, College of MedicineDepartment of Orthopaedics, Shang-Ho Hospital (GR, CHC, YHT) Taipei Medical University, Taipei, TaiwanDepartment of Orthopaedic Surgery, National Taiwan University Hospital Hsin Chu Branch, Hsin-Chu, Taiwan (JSS)Department of Orthopaedics, Shang-Ho Hospital (CHC, GR, YHT)Department of Orthopaedics, School of Medicine, National Taiwan University Hospital Hsin Chu Branch, Hsin-Chu, Taiwan (JSS)
| | - Gary Rau
- Institute of Clinical Medicine (YJK, JSS) National Yang Ming University, Taipei, TaiwanInstitute of Microbiology and Immunology (CHC) National Yang Ming University, Taipei, TaiwanInstitute of Traditional Medicine (THT, YHT) National Yang Ming University, Taipei, TaiwanDepartment of Orthopaedics (YJK), School of Medicine, College of MedicineGraduate Institute of Clinical Medicine (JSS, GR), School of Medicine, College of MedicineDepartment of Orthopaedics, Shang-Ho Hospital (GR, CHC, YHT) Taipei Medical University, Taipei, TaiwanDepartment of Orthopaedic Surgery, National Taiwan University Hospital Hsin Chu Branch, Hsin-Chu, Taiwan (JSS)Department of Orthopaedics, Shang-Ho Hospital (CHC, GR, YHT)Department of Orthopaedics, School of Medicine, National Taiwan University Hospital Hsin Chu Branch, Hsin-Chu, Taiwan (JSS)
| | - Chia-Hsien Chen
- Institute of Clinical Medicine (YJK, JSS) National Yang Ming University, Taipei, TaiwanInstitute of Microbiology and Immunology (CHC) National Yang Ming University, Taipei, TaiwanInstitute of Traditional Medicine (THT, YHT) National Yang Ming University, Taipei, TaiwanDepartment of Orthopaedics (YJK), School of Medicine, College of MedicineGraduate Institute of Clinical Medicine (JSS, GR), School of Medicine, College of MedicineDepartment of Orthopaedics, Shang-Ho Hospital (GR, CHC, YHT) Taipei Medical University, Taipei, TaiwanDepartment of Orthopaedic Surgery, National Taiwan University Hospital Hsin Chu Branch, Hsin-Chu, Taiwan (JSS)Department of Orthopaedics, Shang-Ho Hospital (CHC, GR, YHT)Department of Orthopaedics, School of Medicine, National Taiwan University Hospital Hsin Chu Branch, Hsin-Chu, Taiwan (JSS)
| | - Tung-Hu Tsai
- Institute of Clinical Medicine (YJK, JSS) National Yang Ming University, Taipei, TaiwanInstitute of Microbiology and Immunology (CHC) National Yang Ming University, Taipei, TaiwanInstitute of Traditional Medicine (THT, YHT) National Yang Ming University, Taipei, TaiwanDepartment of Orthopaedics (YJK), School of Medicine, College of MedicineGraduate Institute of Clinical Medicine (JSS, GR), School of Medicine, College of MedicineDepartment of Orthopaedics, Shang-Ho Hospital (GR, CHC, YHT) Taipei Medical University, Taipei, TaiwanDepartment of Orthopaedic Surgery, National Taiwan University Hospital Hsin Chu Branch, Hsin-Chu, Taiwan (JSS)Department of Orthopaedics, Shang-Ho Hospital (CHC, GR, YHT)Department of Orthopaedics, School of Medicine, National Taiwan University Hospital Hsin Chu Branch, Hsin-Chu, Taiwan (JSS)
| | - Yang-Hwei Tsuang
- Institute of Clinical Medicine (YJK, JSS) National Yang Ming University, Taipei, TaiwanInstitute of Microbiology and Immunology (CHC) National Yang Ming University, Taipei, TaiwanInstitute of Traditional Medicine (THT, YHT) National Yang Ming University, Taipei, TaiwanDepartment of Orthopaedics (YJK), School of Medicine, College of MedicineGraduate Institute of Clinical Medicine (JSS, GR), School of Medicine, College of MedicineDepartment of Orthopaedics, Shang-Ho Hospital (GR, CHC, YHT) Taipei Medical University, Taipei, TaiwanDepartment of Orthopaedic Surgery, National Taiwan University Hospital Hsin Chu Branch, Hsin-Chu, Taiwan (JSS)Department of Orthopaedics, Shang-Ho Hospital (CHC, GR, YHT)Department of Orthopaedics, School of Medicine, National Taiwan University Hospital Hsin Chu Branch, Hsin-Chu, Taiwan (JSS)
| |
Collapse
|
20
|
Zhang H, Dong Y, Qi B, Liu L, Zhou G, Bai X, Yang C, Zhao D, Zhao Y. Preventive Effects of Collagen Peptide from Deer Sinew on Bone Loss in Ovariectomized Rats. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE 2014; 2014:1-9. [DOI: org/10.1155/2014/627285] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 07/02/2024]
Abstract
Deer sinew (DS) has been used traditionally for various illnesses, and the major active constituent is collagen. In this study, we assessed the effects of collagen peptide from DS on bone loss in the ovariectomized rats. Wister female rats were randomly divided into six groups as follows: sham-operated (SHAM), ovariectomized control (OVX), OVX given 1.0 mg/kg/week nylestriol (OVX + N), OVX given 0.4 g/kg/day collagen peptide (OVX + H), OVX given 0.2 g/kg/day collagen peptide (OXV + M), and OVX given 0.1 g/kg/day collagen peptide (OXV + L), respectively. After 13 weeks of treatment, the rats were euthanized, and the effects of collagen peptide on body weight, uterine weight, bone mineral density (BMD), serum biochemical indicators, bone histomorphometry, and bone mechanics were observed. The data showed that BMD and concentration of serum hydroxyproline were significantly increased and the levels of serum calcium, phosphorus, and alkaline phosphatase were decreased. Besides, histomorphometric parameters and mechanical indicators were improved. However, collagen peptide of DS has no effect on estradiol level, body weight, and uterine weight. Therefore, these results suggest that the collagen peptide supplementation may also prevent and treat bone loss.
Collapse
Affiliation(s)
- He Zhang
- Changchun University of Chinese Medicine, Boshuo Road 1035, Changchun, Jilin 130117, China
- The Affiliated Hospital to Changchun University of Chinese Medicine, Gongnong Road 1478, Changchun, Jilin 130021, China
| | - Ying Dong
- Changchun University of Chinese Medicine, Boshuo Road 1035, Changchun, Jilin 130117, China
| | - Bin Qi
- Changchun University of Chinese Medicine, Boshuo Road 1035, Changchun, Jilin 130117, China
| | - Li Liu
- Changchun University of Chinese Medicine, Boshuo Road 1035, Changchun, Jilin 130117, China
| | - Guangxin Zhou
- Changchun University of Chinese Medicine, Boshuo Road 1035, Changchun, Jilin 130117, China
| | - Xueyuan Bai
- Changchun University of Chinese Medicine, Boshuo Road 1035, Changchun, Jilin 130117, China
| | - Chunhui Yang
- The Affiliated Hospital to Changchun University of Chinese Medicine, Gongnong Road 1478, Changchun, Jilin 130021, China
| | - Daqing Zhao
- Changchun University of Chinese Medicine, Boshuo Road 1035, Changchun, Jilin 130117, China
| | - Yu Zhao
- Changchun University of Chinese Medicine, Boshuo Road 1035, Changchun, Jilin 130117, China
| |
Collapse
|
21
|
|
22
|
Franceschetti T, Kessler CB, Lee SK, Delany AM. miR-29 promotes murine osteoclastogenesis by regulating osteoclast commitment and migration. J Biol Chem 2013; 288:33347-60. [PMID: 24085298 DOI: 10.1074/jbc.m113.484568] [Citation(s) in RCA: 103] [Impact Index Per Article: 9.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022] Open
Abstract
Osteoclast differentiation is regulated by transcriptional, post-transcriptional, and post-translational mechanisms. MicroRNAs are fundamental post-transcriptional regulators of gene expression. The function of the miR-29 (a/b/c) family in cells of the osteoclast lineage is not well understood. In primary cultures of mouse bone marrow-derived macrophages, inhibition of miR-29a, -29b, or -29c diminished formation of TRAP (tartrate-resistant acid phosphatase-positive) multinucleated osteoclasts, and the osteoclasts were smaller. Quantitative RT-PCR showed that all miR-29 family members increased during osteoclast differentiation, in concert with mRNAs for the osteoclast markers Trap (Acp5) and cathepsin K. Similar regulation was observed in the monocytic cell line RAW264.7. In stably transduced RAW264.7 cell lines expressing an inducible miR-29 competitive inhibitor (sponge construct), miR-29 knockdown impaired osteoclastic commitment and migration of pre-osteoclasts. However, miR-29 knockdown did not affect cell viability, actin ring formation, or apoptosis in mature osteoclasts. To better understand how miR-29 regulates osteoclast function, we validated miR-29 target genes using Luciferase 3'-UTR reporter assays and specific miR-29 inhibitors. We demonstrated that miR-29 negatively regulates RNAs critical for cytoskeletal organization, including Cdc42 (cell division control protein 42) and Srgap2 (SLIT-ROBO Rho GTPase-activating protein 2). Moreover, miR-29 targets RNAs associated with the macrophage lineage: Gpr85 (G protein-coupled receptor 85), Nfia (nuclear factor I/A), and Cd93. In addition, Calcr (calcitonin receptor), which regulates osteoclast survival and resorption, is a novel miR-29 target. Thus, miR-29 is a positive regulator of osteoclast formation and targets RNAs important for cytoskeletal organization, commitment, and osteoclast function. We hypothesize that miR-29 controls the tempo and amplitude of osteoclast differentiation.
Collapse
|